- Home
- ZIP vs TNYA Comparison
ZIP vs TNYA Comparison
Compare ZIP & TNYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZIP
- TNYA
- Stock Information
- Founded
- ZIP 2010
- TNYA 2016
- Country
- ZIP United States
- TNYA United States
- Employees
- ZIP N/A
- TNYA N/A
- Industry
- ZIP Diversified Commercial Services
- TNYA Medicinal Chemicals and Botanical Products
- Sector
- ZIP Consumer Discretionary
- TNYA Health Care
- Exchange
- ZIP Nasdaq
- TNYA Nasdaq
- Market Cap
- ZIP 365.3M
- TNYA 326.0M
- IPO Year
- ZIP 2021
- TNYA 2021
- Fundamental
- Price
- ZIP $4.23
- TNYA $1.33
- Analyst Decision
- ZIP Hold
- TNYA Strong Buy
- Analyst Count
- ZIP 4
- TNYA 5
- Target Price
- ZIP $4.88
- TNYA $8.60
- AVG Volume (30 Days)
- ZIP 856.2K
- TNYA 4.0M
- Earning Date
- ZIP 11-05-2025
- TNYA 11-10-2025
- Dividend Yield
- ZIP N/A
- TNYA N/A
- EPS Growth
- ZIP N/A
- TNYA N/A
- EPS
- ZIP N/A
- TNYA N/A
- Revenue
- ZIP $448,299,000.00
- TNYA N/A
- Revenue This Year
- ZIP N/A
- TNYA N/A
- Revenue Next Year
- ZIP $10.02
- TNYA N/A
- P/E Ratio
- ZIP N/A
- TNYA N/A
- Revenue Growth
- ZIP N/A
- TNYA N/A
- 52 Week Low
- ZIP $3.35
- TNYA $0.36
- 52 Week High
- ZIP $10.08
- TNYA $4.01
- Technical
- Relative Strength Index (RSI)
- ZIP 44.01
- TNYA 41.94
- Support Level
- ZIP $4.08
- TNYA $1.20
- Resistance Level
- ZIP $4.84
- TNYA $1.56
- Average True Range (ATR)
- ZIP 0.27
- TNYA 0.15
- MACD
- ZIP 0.01
- TNYA -0.02
- Stochastic Oscillator
- ZIP 26.36
- TNYA 27.78
About ZIP ZipRecruiter Inc.
ZipRecruiter Inc is an online employment marketplace. It connects millions of job seekers with companies of all sizes. It is a two-sided marketplace for work that simplifies the job market for both job seekers and employers. Unlike traditional online job sites, ZipRecruiter works like a matchmaker curating job opportunities for job seekers, and candidates for employers.
About TNYA Tenaya Therapeutics Inc.
Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration and precision medicine.